Pancreas or Kidney Transplant: Will It Help or Hurt Your Diabetic Retinopathy?
Transplant and Your Retinopathy at a Glance
A few eye changes cannot wait. Call your eye doctor or retina specialist the same day if you notice any of these:
- Sudden vision loss in one eye or both eyes.
- A curtain or shadow moving across your sight.
- A sudden shower of new floaters.
- Flashing lights that are new to you.
- Severe eye pain, a red painful eye, or halos around lights.
In diabetic eye disease, fragile new vessels can bleed into the jelly of the eye, which may look like a few dark floaters after a small bleed or may block vision after a large one, and scar tissue can lead to a detached retina.1 Both are more common in advanced diabetic eye disease. When the retina pulls away but the center of your sight is still spared, repair within a day of being seen tends to end with better vision than a later repair.2 Most people never see any of these signs. If you do, care usually works well when you move fast. So make the call, and let the eye team decide.
A transplant is usually good news for your eyes over the long run, and a little unsettling in the short run. Restoring normal blood sugar and kidney function together tends to leave retinopathy stable or improved in most recipients, though a minority still progress.3 In one year-long study of people who got a pancreas and a kidney together, retinopathy stayed stable in about 63 of every 100 patients, and average reading vision did not change.4 The trade is that the first six to twelve months can be a rough patch, which is why the eye plan matters as much as the surgical one.
Early worsening is a temporary step backwards in retinopathy, seen in the first months after blood sugar drops sharply. It is not a sign the transplant failed. It was measured in the Diabetes Control and Complications Trial, where retinopathy worsened at the 6 or 12 month check in about 13 of every 100 people on intensive insulin treatment, against about 8 of every 100 on the conventional regimen.5 A new pancreas makes the same kind of sharp correction, so the same pattern can follow it. The reassuring part came next in that trial: the long-term gain was far larger than the short-term dip.
What Each Transplant Actually Changes Inside Your Eye
A kidney transplant does not touch your blood sugar. It changes what failing kidneys do to the retina: fluid overload, high blood pressure, and the protein leak that can drive swelling at the macula (the small central patch of retina you read with). In a nationwide analysis of people with type 2 diabetes, the risk of swelling at the macula climbed step by step as kidney function fell and was highest at end-stage kidney disease, while kidney transplant recipients carried a lower risk of that swelling than others with end-stage disease.6 So a new kidney often helps the wet, swollen side of diabetic eye disease. It does nothing about the diabetes itself.
A pancreas transplant restores your own insulin supply, so blood sugar comes down toward a normal range while the graft works. That removes the driver of retinopathy at its root. The change is abrupt, though, and abrupt is what the retina dislikes at first. In a single-center series of 303 eyes from 153 pancreas transplant recipients followed a mean of 4.2 years, retinopathy stayed stable in most eyes, about 21 of every 100 eyes progressed over that time, and about 19 of every 100 eyes met the study's definition of early worsening in the first year.7 The long game favors the pancreas. The first year asks for patience.
Most people with type 1 diabetes who need a new kidney still have the diabetes that damaged the first one, and a kidney alone leaves the new organ exposed to it. Doing both together, an operation called simultaneous pancreas-kidney transplant, fixes the filtering and the blood sugar at once. For the eye, this is the best studied of the three routes. In 48 people followed a median of 17 months after pancreas-kidney transplant, 35 of the 36 who already had laser-treated or proliferative retinopathy, the advanced stage where fragile new blood vessels grow, had disease that held steady afterwards.3 Holding steady, at that stage, is a good result.
Here is the honest limit, worth hearing early. A transplant changes the chemistry that damages your retina. It does not repair damage already done. Scar tissue and sight already lost to old bleeding or swelling are not expected to come back because a new organ started working. Panretinal laser, which treats the outer retina, and injections that block a growth signal inside the eye are the established treatments for proliferative diabetic retinopathy, and an eye doctor gives them, before or after any transplant.8 The transplant takes your foot off the accelerator. Eye treatment is the brake. You often need both.
Kidney, Pancreas, or Both: A Side-by-Side Look at Eye Effects
Here is how the three routes tend to differ for the eye. Every row is a general pattern from group studies, not a forecast for your eyes.
| Transplant route | Main effect on the retina | What to watch for |
|---|---|---|
| Kidney alone | Lowers the fluid and blood pressure load that feeds swelling at the macula; blood sugar unchanged | Retinopathy can keep progressing, because the diabetes continues |
| Pancreas alone | Normalizes blood sugar, which tends to stabilize retinopathy over years | Carries the highest early worsening risk of the three routes |
| Pancreas and kidney together | Addresses both the sugar and the kidney load; best studied route for advanced retinopathy | Early worsening still possible, especially after recent laser |
Your kidneys and your diabetes drive this choice, not your eyes. If your kidneys have failed and you have type 1 diabetes, the combined operation is the common recommendation. If your kidneys have failed but your type 2 diabetes is reasonably controlled, a kidney alone is often the sensible route. A pancreas alone is generally kept for people whose kidneys still work well but whose blood sugar swings are dangerous. Pancreas transplant alone was one of the factors linked to early worsening in the largest single-center series, alongside panretinal laser given within the year before surgery.7
These studies are small, single-center, and mostly retrospective, and none assigned people to a route at random. People chosen for a pancreas transplant differ from those chosen for a kidney alone in age, in years of diabetes, and in retinopathy grade, so a head-to-head reading is unreliable. The evidence is also mixed on how much the speed of blood sugar correction matters, since a matched study of 1,150 people with type 2 diabetes and mild or moderate background retinopathy found no link between a rapid fall in A1C, the blood test that reflects your average sugar over about three months, and early worsening.9 Your own starting grade shapes your risk more than the route label does.
Early Worsening: Why Vision Can Dip Before It Settles
Often enough to plan for, rarely enough not to dread. In the pancreas transplant series above, about 19 of every 100 eyes showed early worsening in the first year, meaning new or worse swelling at the macula needing injections, or retinopathy bad enough to need laser or surgery inside the eye.7 A study of 43 pancreas-kidney recipients found about 37 of every 100 met a combined worsening measure over 12 months, though the severity was generally low and mild swelling settled on its own in roughly half of those affected.4 Most of that activity shows up on a scan before you would notice it.
A retina that has lived with years of high sugar has rebuilt its blood supply around that setting. Drop the sugar quickly and blood flow, fluid balance, and growth signals all shift at once, so vessels that were barely coping can leak or sprout. The American Academy of Ophthalmology notes that rapid, tight glucose control can bring on accelerated or early onset of diabetic retinopathy.8 The American Diabetes Association adds that retinopathy status should be reassessed whenever glucose-lowering therapy is intensified, because a fast A1C fall has been linked with initial worsening.10 A transplant is the fastest intensification there is.
Risk clusters in fairly predictable places. Advanced retinopathy before surgery, a very high A1C that then falls hard, and recent laser all raise the odds. Panretinal laser within the year before transplant, and a pancreas transplant without a kidney, were both linked with early worsening in the 153-patient series.7 If that describes you, it is an argument for tighter eye monitoring around the surgery, not an argument against the transplant, which is usually the thing keeping you alive.
The Longer-Term Picture and the Risks Worth Knowing
Past the first year the picture generally turns favourable, though not for everyone. In a follow-up of 18 people a mean of 4.6 years after pancreas-kidney transplant, 11 had retinopathy that stayed stable or improved with no further treatment, while about 5 progressed to sight-threatening proliferative disease and several needed laser or injections along the way.11 That study is small, so read it as a direction rather than a rate. Stability is the common outcome, and it is a stability that still needs checking.
The drugs that protect your new organ have their own eye effects, and steroids are the main one to know about. In 37 kidney transplant recipients on long-term low-dose steroids, 22 had at least one abnormality on eye examination, most often changes at the back of the eye resembling central serous chorioretinopathy, a small blister of fluid under the retina, in 10 people, and a fine sheet of scar tissue on the macula in 6.12 That was one small series with no comparison group, so it cannot show the steroids caused those findings. None of this is a reason to change your medicines on your own. It is a reason to bring your full drug list to eye appointments, and to keep those appointments.
Anti-rejection drugs open a small door to infections at the back of the eye, and these are treatable when caught early. The one most often discussed is cytomegalovirus retinitis, an infection of the retina by a common virus that a healthy immune system keeps quiet. Among 1,198 organ or marrow transplant recipients seen in one hospital eye department over ten years, 33 developed a retinal complication, of whom 11 had cytomegalovirus retinitis and 5 had a fungal infection, and these cases clustered around rejection episodes or body-wide infection and responded to standard treatment.13 Blurring or blank patches during a rejection episode deserve a prompt eye check.
Every number on this page describes a group. None of them tells you what your eyes will do. Two people with the same retinopathy grade, the same A1C, and the same operation can land in different places, and these studies cannot tell them apart in advance. Your ophthalmologist can say something far more useful than any average: what your own scans show, how they have changed, and what that trend suggests. Treat these figures as a way to ask better questions, not as a forecast.
Protecting Your Sight Before and After the Operation
The most valuable eye appointment in this process happens before surgery. It sets your baseline, and it leaves time to finish any laser or injection treatment. The Diabetes Control and Complications Trial investigators concluded that eye monitoring before intensive treatment starts is appropriate for people whose control has been poor, and that for those nearing high-risk stages it can be sensible to delay intensification until laser treatment is complete.5 Ask for a dilated examination with retinal photographs and a scan of the macula, and ask for a copy.
More often than the routine yearly visit, at least until things settle. The trial investigators suggested eye review at roughly three month intervals for 6 to 12 months after blood sugar is sharply improved in people whose control had been poor.5 Standing guidance is an initial dilated comprehensive eye exam and at least yearly exams after that, with a fresh look whenever glucose-lowering treatment is intensified.10 Your own schedule should come from your retina specialist and depends on how advanced your retinopathy was going in.
Home checking will not replace a scan, but it catches change between visits. Cover one eye, then the other, and look at a doorframe or a printed grid at your reading distance. Look for lines that bend, a grey or missing patch, or a difference between the two eyes that was not there last week. Do it on the same day each week. More floaters, blurry or changing vision, dark or blank areas, and poor night vision are the usual symptoms of diabetic retinopathy, and the American Academy of Ophthalmology advises calling your ophthalmologist right away when you notice a change in one eye or both.1
When to Call, and Who to Call
Treat these as urgent and do not wait for a routine slot: sudden loss of vision, a curtain or shadow sweeping across your sight, a sudden shower of new floaters or flashing lights, or a red and painful eye with halos around lights. The American Academy of Ophthalmology lists bleeding into the jelly of the eye and a detached retina among the ways diabetic retinopathy damages sight, and advises calling your ophthalmologist right away if you notice vision changes in one eye or both.1 If you cannot reach your eye clinic within a few hours, go to an emergency room with an eye service. Acting the same day is what keeps a treatable problem treatable.
Slower changes still deserve attention, just not a scramble. Book within a week for vision that has become gradually blurrier, straight lines that look wavy, a new dull ache in the eye, or reading vision that has quietly slipped. These patterns fit swelling at the macula or a rise in eye pressure more than a detachment. A change in vision in one eye or both is a reason to contact your ophthalmologist rather than wait it out.1 Say that you are a transplant recipient when you book, because it changes how fast a clinic will fit you in.
Between the urgent and the gradual sits the routine, and the routine is what protects most people's sight. A yearly dilated eye examination is recommended from 5 years after a type 1 diabetes diagnosis, and from the time of diagnosis in type 2 diabetes, with more frequent review when retinopathy is present.8 After a transplant, expect closer intervals in the first year, then a return toward yearly review once your retina has been stable for a while. Book the next appointment before you leave the current one.
Questions People Ask Before Transplant
No. A transplant changes the conditions that damage the retina, so it can slow or halt further damage, but it will not undo scarring or sight already lost. The realistic hope is stability. In one series of pancreas-kidney recipients, 35 of the 36 people who already had laser-treated or proliferative retinopathy had disease that held steady afterwards, and among the 12 with earlier background changes, 5 improved while 4 progressed.3 Improvement happens, mostly in milder disease. With advanced retinopathy, holding the line is a genuinely good result.
Often yes, and it is a decision for your retina specialist and your transplant team together. Completing recommended laser before a sharp drop in blood sugar puts the retina in a steadier state for the change that follows. Trial investigators suggested that for people close to high-risk stages of retinopathy, it can be appropriate to delay intensive glucose treatment until laser is complete.5 Transplant timing is rarely fully in your control, so raise this at the assessment stage.
Eyes alone are almost never the reason. A pancreas transplant carries surgical risk and a lifetime of anti-rejection medicine, and it is usually offered for kidney failure or dangerous blood sugar swings, with the eye benefit as an extra. Retinopathy stays stable in most recipients over the years that follow, while a minority still progress and need treatment.7 That is a reasonable bonus to a decision made on other grounds, and a thin basis for the decision alone.
A kidney transplant often helps, because much of the swelling at the macula in kidney failure is driven by fluid overload and blood pressure. In a nationwide analysis, that swelling became more likely as kidney function declined and was most likely at end-stage kidney disease, while kidney transplant recipients carried a lower risk than others with end-stage disease.6 That is an association from a large group, not a promise for your eyes, and it is not a reason to stop eye treatment.
Questions People Ask After Transplant
Possibly, in the specific and usually temporary sense of early worsening. A sharp fall in blood sugar can push the retina backwards for a few months before it settles. About half of those who showed early worsening in the Diabetes Control and Complications Trial had recovered by 18 months, and the few who developed severe disease responded well to treatment.5 Fluid shifts and a changing glasses prescription can also blur vision early on. Get it examined, so the treatable causes are found.
Yes. Injections into the eye and retinal laser are routinely given to transplant recipients, and anti-rejection medicine is not a barrier to either. In long-term follow-up after pancreas-kidney transplant, recipients went on receiving macular laser, panretinal laser, and injection treatment as needed.11 Tell your eye doctor your full medicine list and any recent rejection episode, and tell your transplant team when an eye procedure is booked. The coordination matters more than the procedures.
Yes, and this may be the most important sentence on the page. Normal blood sugar lowers the pressure on your retina. It does not discharge you from eye care. In long-term follow-up after pancreas-kidney transplant, about 5 of 18 people progressed to sight-threatening proliferative retinopathy despite good metabolic results, which is why ongoing eye follow-up was judged necessary.11 Steroid-related lens and pressure changes are a second reason. Keep at least a yearly dilated examination for life.
Not always, but they are always worth a same-day call rather than a wait-and-see. You cannot tell from the outside which floaters matter. In diabetic eyes, a sudden shower of them can mean bleeding from fragile new vessels, and that needs looking at quickly. The American Academy of Ophthalmology describes a small bleed from these vessels as a few dark floaters and a large one as blocked vision, and advises calling your ophthalmologist right away when your vision changes.1 Describe what you saw and when it started when you ring.
- What grade is my retinopathy right now, and do I have swelling at the macula?
- Is there laser or injection treatment you would rather complete before my transplant?
- Given my starting grade and A1C, how likely is early worsening for me?
- How often do you want to see me during the first year after surgery?
- Which of my transplant medicines could affect my eyes, and what would you look for?
- What symptoms should make me call you the same day rather than wait?
- Who do I ring out of hours, and does that number reach an eye service?
- Can I have a copy of my retinal photographs and macular scan for my records?
- American Academy of Ophthalmology, EyeSmart (2025). Diabetic Retinopathy Symptoms.
- American Journal of Ophthalmology (2022). Impact of the Time to Surgery on Visual Outcomes for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis.
- Transplant International (2005). Effects of pancreas-kidney transplantation on diabetic retinopathy.
- American Journal of Transplantation (2020). Early worsening of diabetic retinopathy after simultaneous pancreas and kidney transplantation: Myth or reality?.
- Archives of Ophthalmology (DCCT Research Group) (1998). Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
- Ophthalmology Science (2025). Nationwide Analysis of Progressive Kidney Function Decline and Diabetic Macular Edema in Type 2 Diabetes.
- Transplantation (2018). Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening.
- American Academy of Ophthalmology (2024). Diabetic Retinopathy Preferred Practice Pattern.
- Diabetes Care (2023). Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes.
- American Diabetes Association, Diabetes Care (2026). 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes 2026.
- Journal of Clinical Medicine (2025). Persistent Need for Ophthalmic Follow-Up After Simultaneous Pancreas-Kidney Transplantation: Long-Term Effects on Diabetic Retinopathy and Quality of Life.
- Graefe's Archive for Clinical and Experimental Ophthalmology (2017). Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.
- Transplantation (2007). Retinal complications in patients with solid organ or bone marrow transplantations.